Jo. Funk et al., PENTOXIFYLLINE EXERTS SYNERGISTIC IMMUNOMODULATORY EFFECTS IN COMBINATION WITH DEXAMETHASONE OR CYCLOSPORINE-A, International journal of immunopharmacology, 17(12), 1995, pp. 1007-1016
The methylxanthine derivative pentoxifylline (PTX) is an immunomodulat
ory agent with incompletely characterized effects on cytokine producti
on. To analyse these effects and to delineate new combination strategi
es in immunotherapy, we have investigated immunomodulatory properties
of PTX in combination with dexamethasone (DEX) or cyclosporin A (CsA).
Stimulated human peripheral blood mononuclear cells were treated with
clinically relevant concentrations of PTX (12.5-100 mu g/ml), DEX (0.
01-10 mu M) or CsA (12.5-50 ng/ml), alone or in combination. With incr
easing doses of PTX the maximum supernatant titres of tumour necrosis
factor (TNF)-alpha, interleukin (IL)-2 and interferon (IFN)-gamma decr
eased concomitantly, and all cultures co-treated with DEX showed syner
gism. Release of IL-6 was not consistently altered under PTX treatment
. Similarly, PTX and CsA synergistically inhibited the release of IL-2
, IFN-gamma and, to a lesser degree, TNF-alpha. Although PTX alone did
not significantly reduce lymphoproliferation, both combinations of dr
ugs synergistically inhibited this process. Furthermore, to demonstrat
e that the key mechanism of PTX-induced effects is an increase in intr
acellular cyclic adenosine 3':5'-monophosphate (cAMP) levels, identica
l experiments were performed using dibutyryl-cAMP instead of PTX. In c
ultures treated with PTX and DEX, expression of different cell recepto
rs was analysed. Expression of IL-2 receptor (IL-2R) was reduced in cu
ltures treated with PTX, and combination with DEX led to further reduc
tion. Expression of intercellular adhesion molecule (ICAM)-1 and of le
ucocyte function antigen (LFA)-1 alpha was also synergistically reduce
d, though to a lesser degree. HLA-DR expression remained unchanged. In
conclusion, we demonstrate that clinically relevant levels of PTX exe
rt profound immunomodulatory effects in vitro, and that the combined t
reatment with DEX or CsA has synergistic effects.